Digital Content 
NEWS #PharmaBuzz
07 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/07/3201129/0/en/Secura-Bio-Presents-Extended-Follow-Up-Analyses-from-Phase-2-PRIMO-Trial-in-Patients-with-Relapsed-Refractory-peripheral-T-cell-lymphoma-at-the-2025-American-Society-of-Hematology-.html
09 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/09/3095721/0/en/Secura-Bio-Announces-First-Patient-Dosed-in-Phase-3-TERZO-Study-of-COPIKTRA-duvelisib-in-Relapsed-Refractory-Nodal-T-follicular-Helper-Cell-Lymphoma.html
09 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/09/2993617/0/en/New-Combination-Data-of-Secura-Bio-s-COPIKTRA-duvelisib-Presented-at-the-2024-American-Society-of-Hematology-Meeting.html
09 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/09/2993615/0/en/Secura-Bio-Presented-New-Data-from-its-Phase-2-PRIMO-Trial-of-Copiktra-Duvelisib-in-Relapsed-or-Refractory-Peripheral-T-cell-Lymphoma-and-Announced-Plans-for-its-Phase-3-TERZO-Tria.html
06 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/06/2975561/0/en/Secura-Bio-Announces-Poster-Presentation-Highlighting-New-COPIKTRA-duvelisib-Data-for-the-Treatment-of-Patients-With-Peripheral-T-Cell-Lymphoma-and-Other-Advanced-Hematologic-Malig.html
23 Mar 2023
// Zachary Brennan ENDPTS
https://endpts.com/secura-bio-to-keep-offering-blood-cancer-drug-despite-negative-odac-vote-os-questions/
Share 